Xerox Holdings Corporation, together with its subsidiaries, operates as a workplace technology company that integrates hardware, services, and software for enterprises in North America, Latin America, Europe, the Middle East, Africa, India, and internationally. It operates in two segments: Print and Other, and Xerox Financial Services (XFS). The company engages in the design, development, and sale of document systems, solutions, and services, as well as associated technology offerings, including IT and software products and services. It also offers workplace solutions, which includes the sale of equipment, software, supplies, and the associated technical services; Entry, which is comprised of A4 desktop monochrome and color printers, and multifunction printers; Mid-range, which is comprised of A3 devices; and ConnectKey software. In addition, the company offers production solutions, which includes presses and solutions that provides black-and-white and full-color, as well as on-demand printing; xerographic and inkjet presses; and FreeFlow. Further, it offers Xerox services, which includes Managed Print Services, IT solutions, Capture and Content Services, and Customer Engagement Services; XFS, which offers financing for direct channel customer purchases of Xerox equipment and solutions, and lease financing to Xerox equipment and solution purchases through indirect channels; CareAR; DocuShare; and XMPie. It also invests in startups and early/mid-stage growth companies. The company sells its products through its direct sales force, distributors, independent agents, dealers, value-added resellers, systems integrators, and e-commerce marketplaces. The company was formerly known as Xerox Corporation and changed its name to Xerox Holdings Corporation in August 2019. Xerox Holdings Corporation was founded in 1903 and is headquartered in Norwalk, Connecticut.

Xerox Holdings Corporation

Recursion Pharmaceuticals ( ($RXRX) ) just unveiled an update. On December 8, 2025, Recursion Pharmaceuticals announced positive results from the P...

Recursion Pharmaceuticals Reports Positive TUPELO Trial Results

The latest announcement is out from Recursion Pharmaceuticals ( ($RXRX) ). On November 26, 2025, Recursion Pharmaceuticals filed a prospectus suppl...

Recursion Pharmaceuticals Registers Resale of 7 Million Shares

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several notable portfolio adjustments on Thursday, November 20, as revealed in daily fun...

Current Quarter	$0.14	Next Quarter	$0.01
Current Year	$-0.35	Next Year	$1.01
QoQ Growth	-92.9%	YoY Growth	+388.6%
3Y EPS CAGR	-61.3%	Target Price	$3.75
Consensus	Buy	Upside	+43.7%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	XRX	$2.61	0.00%	2.08M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	XRX	$2.61	0%	2.08M
3
4
5
6

XRX

XRX

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Xerox Holdings Corporation Data in Excel

Get Xerox Holdings Corporation Data in Excel